Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

67%(2 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_3

75%

Ph phase_1

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

Phase 3Large-scale testing

3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 3

Trials by Phase

Phase 11 (25.0%)

Phase 33 (75.0%)

Trials by Status

terminated125%

completed375%

Recent Activity

0 active trials

Showing 4 of 4

completedphase_3

Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)

NCT00875394

completedphase_3

Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)

NCT00541775

completedphase_1

A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)

NCT00975052

terminatedphase_3

Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)

NCT00543361

Clinical Trials (4)

Showing 4 of 4 trials

NCT00875394Phase 3

Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)

Completed

NCT00541775Phase 3

Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)

Completed

NCT00975052Phase 1

A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)

Completed

NCT00543361Phase 3

Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)

Terminated

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4